Nuclear receptor corepressor 1 represses cardiac hypertrophy

Area of Science:

• Cardiovascular Biology
• Molecular Cardiology
• Epigenetics

Background:

• The role of nuclear receptor corepressor 1 (NCoR1) in heart cells (cardiomyocytes) is not well understood.
• Its involvement in both normal heart function and disease states like cardiac hypertrophy remains unclear.

Purpose of the Study:

• To investigate the function of NCoR1 in cardiomyocytes.
• To determine the physiological and pathological implications of NCoR1 in the context of cardiac hypertrophy.

Main Methods:

• Generated cardiomyocyte-specific NCoR1 knockout (CMNKO) mice for in vivo studies.
• Utilized cell culture models to study NCoR1's effects on phenylephrine-induced cardiomyocyte hypertrophy.
• Performed mechanistic studies involving protein-protein interactions and gene expression analysis.

Main Results:

• CMNKO mice exhibited baseline cardiac hypertrophy and exacerbated dysfunction under pressure overload.
• NCoR1 knockdown worsened hypertrophy, while overexpression mitigated it.
• NCoR1 was found to interact with MEF2a and HDACs to suppress hypertrophy-related genes.

Conclusions:

• NCoR1 plays a crucial role in repressing cardiac hypertrophy by cooperating with MEF2 and HDACs.
• Targeting NCoR1 and the MEF2/HDACs complex presents a potential therapeutic strategy for pathological cardiac hypertrophy.